18F-fluorodeoxyglucose positron emission tomography combined with computed tomography for bladder cancer staging: Diagnostic accuracy and prognostic implications
Bladder · 2025
DOI: 10.14440/bladder.0044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bladder, 2025. Verfasst von Tran Ngoc An Huynh und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Monash Health, Melbourne 3168, Victoria, Australia. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Muscle-invasive bladder cancer has a poor prognosis. Accurate lymph node (LN) staging is crucial, yet conventional imaging demonstrates limited sensitivity for detecting metastasis, necessitating improved pre-operative assessment.
Objectives
To evaluate the diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography combined with computed tomography (FDG-PET/CT) compared to computed tomography (CT) for LN staging in patients with bladder cancer(BC) undergoing radical cystectomy (RC), and to assess the impact of imaging-determined nodal status on survival outcomes.
Methods
This retrospective study analyzed 138 patients who underwent RC and pelvic LN dissection (PLND) at a multisite tertiary institution from 2008 to 2021. All patients received either pre-operative CT or FDG-PET/CT within 8 weeks before RC and PLND. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value for detecting LN metastasis (LNM) were calculated using pathological analysis as the reference standard. Kaplan–Meier survival analysis and Cox regression were employed to assess overall survival (OS).
Results
FDG-PET/CT exhibited higher sensitivity (70% vs. 23.3%) and PPV (70% vs. 38.46%) compared to CT, but lower specificity (78.57% vs. 85.7%). Survival outcomes showed statistically significant differences in OS between node-positive and node-negative groups in the FDG-PET/CT cohort, but not in the CT cohort.
Conclusion
FDG-PET/CT provides superior sensitivity and PPV compared to CT for LN staging in BC, facilitating more accurate pre-operative evaluation. The improved prognostic stratification associated with FDG-PET/CT may guide individualized treatment strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Monash Health, Melbourne 3168, Victoria, Australia.
- Faculty of Medicine, Nursing and Health Science, Monash University, Melbourne 3800, Victoria, Australia.
- School of Clinical Sciences, Monash University, Melbourne 3800, Victoria, Australia.
Zitieren
APA
Huynh, T. N. A., Wei, X., Arulshankar, S., Lam, D., Lim, K. Y., Huang, J., Rajarubendra, N., Chu, K., Donnellan, S., & Ranasinghe, W. (2025). 18F-fluorodeoxyglucose positron emission tomography combined with computed tomography for bladder cancer staging: Diagnostic accuracy and prognostic implications. Bladder. https://doi.org/10.14440/bladder.0044
Vancouver
Huynh TNA, Wei X, Arulshankar S, Lam D, Lim KY, Huang J, et al. 18F-fluorodeoxyglucose positron emission tomography combined with computed tomography for bladder cancer staging: Diagnostic accuracy and prognostic implications. Bladder. 2025. doi:10.14440/bladder.0044
BibTeX
@article{Huynh2025,
author = {Huynh, Tran Ngoc An and Wei, Xinyi and Arulshankar, Samiha and Lam, Darren and Lim, Kylie Yen-Yi and Huang, James and Rajarubendra, Nieroshan and Chu, Kevin and Donnellan, Scott and Ranasinghe, Weranja},
title = {18F-fluorodeoxyglucose positron emission tomography combined with computed tomography for bladder cancer staging: Diagnostic accuracy and prognostic implications},
journal = {Bladder},
year = {2025},
doi = {10.14440/bladder.0044}
}
EUVIMED